BrightSpring Q2 revenue up 26% to $2.73B, raises FY2024 guidance

BrightSpring Health Services, Inc.

2024-Q2 EPS reported -$0.14 revenue$5,306,848,000

Revenue $2.73B (+26% YoY); net income $19.4M vs $2.8M in Q2 2023.
Adj. EBITDA $139M (-6.9% YoY) but excluding $30M 2023 QIP, up 16.7%.
Pharmacy Solutions revenue $2.11B (+32%); Provider Services $616M (+8%).
FY2024 guidance raised: revenue $10.45-10.9B, Adj. EBITDA $570-580M.
CEO cites strong segment growth and operational execution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.